Business and People March 2015

March 20, 2015
Applied Clinical Trials Editorial Staff

,
Miraj Barodia

Applied Clinical Trials

New faces among the Pharma Industry rise the ranks.

People

 

Dr. Aaron Bernstein, director of global submissions for Synchrogenix,Certara’s regulatory and medical writing consultancy, has been appointed to the European Medical Writers Association’s Budapest Working Group to help update the International Conference on Harmonisation (ICH) E3 and ICH E6 guidelines for developing clinical study protocols and clinical study reports.

 

 

Veeva Systems announced that industry veteran Alan Mateo will join the company in mid-April as Executive Vice President of Global Sales. Mateo will lead Veeva’s worldwide sales force at time when the company is growing globally and rapidly expanding its customer relationships. He will report to Veeva’s co-founder and CEO, Peter Gassner.

 

Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has appointed Jason Moore as Vice President of Global Program Management.

 

ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its cardiac safety, respiratory, and Clinical Outcome Assessment (COA)/electronic COA (eCOA) consulting group.  Colleen A. McHorney, PhD - an internationally acknowledged thought leader in the field of health outcomes assessment and health services research – has joined ERT as a Senior Scientist in its COA consulting group.

 

Intrinsic Imaging, an FDA audited, ISO 9001 and ISO 13485 certified medical imaging core lab providing imaging core lab services for clinical trials, announces today the appointment of Ms. Amy Zastawney as Vice President of Business Development.  Ms. Amy Zastawney will focus her efforts on the eastern portion of the United States.

 

SynteractHCR, a full-service, international contract research organization (CRO), has hired Etienne Drouet as Vice President, Strategic Development. This is a new position created to augment the depth of the company’s oncology and complex trial expertise. Adding experience to an already capable senior management team brings new perspectives and enhances the team’s skills as this global CRO continues its focus on the small and mid-size biopharma segment.

 

ACM Global Central Laboratory, a diagnostic central laboratory delivering high-quality testing services that optimize clinical trial outcomes, is pleased to announce that Steve Kasay has joined ACM as Chief Information Officer. As CIO, Steve is responsible for providing leadership and strategic direction for ACM’s IT initiatives around the world.

 

Related Content:

Online Extras